Sanyou Biopharmaceuticals is a high-tech biopharmaceutical company driven by the mission of “To make it easy to develop new drugs worldwide”. The company is committed to fundamentally addressing the key challenges at the source of innovative drug development. Powered by its AI-STAL and supported by Sanyou Al-Drug Accelerator（SAI-DA）, Sanyou provides comprehensive, one-stop solutions for innovative drug discovery, with a particular focus on molecular discovery and selection. Sanyou Bio has been dedicated to developing a world-class innovative biological drug R&D hub and to working collaboratively with partners worldwide to accelerate the development of innovative therapeutics. Headquartered in Shanghai, China, Sanyou has established global business centers across Asia, North America, and Europe, forming an international business network. The company currently operates and has planned over 20,000 square meters of R&D and GMP facilities. Sanyou has established strong collaborations with more than 2,000 pharmaceutical and biotech companies worldwide, empowering over 1,200 new drug discovery and development projects. It has completed more than 50 collaboration projects, over 10 of which have advanced to IND approval and clinical development stages. The company has filed over 170 invention patents, with more than 30 granted. It has also obtained over 10 national and international qualifications and system certifications, including National High-Tech Enterprise, Shanghai “Specialized and Innovative” Enterprise, ISO9001, and ISO27001.
We're tracking Sanyou Biopharmaceuticals's market expansion
3 signals in the last 90 days.
How Sanyou Biopharmaceuticals's international expansion compares to its competitors
Sanyou BiopharmaceuticalsYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Sanyou BiopharmaceuticalsYou | 0 | 0 | — | 0 | 0 |
Business Development And Licensing Director
View postingBelfast, Northern Ireland, United Kingdom · 5mo ago
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Sanyou Bio launches Mrna Mab platform for innovative antibody generation, offering advantages in mRNA design and immunization.
Sanyou Bio's AI-STAL platform, developed over a decade, has revolutionized drug discovery with its vast molecule library and advanced technological system.
Sanyou Bio's platform features 10 trillion molecule capacity, enhancing drug R&D efficiency with 10 sub-platforms for various molecule types.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Sanyou Biopharmaceuticals's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
